Corporate partners
Biogen Idec: Together Achieving New Standards of Care.
Biogen Idec has spent the last 15 years committed to research and development in dermatology. From these efforts, AMEVIVE® (alefacept) was developed, the first biologic treatment for adults with moderate to severe chronic plaque psoriasis. Also dedicated to educating people about psoriasis, Biogen Idec launched PsoriasisSupport.com, which offers patients useful articles, advice, and a supportive community.
The link above takes you off the Psoriasis Foundation Web site. The Psoriasis Foundation does not endorse or accept any responsibility for the content of external Web sites. Click here for complete terms of use.
| 
